3Dormandy JA,Rutherford RB.Management of peripheral arterial disease (PAD).TASC Working Group.TransAtlantic Inter-Society Consensus (TASC)[J].J Vasc Surg,2000,31(1 pt 2):S1-S296.
4Hirsch AT,Haskal ZJ,Hertzer NR,et al.ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity,renal,mesenteric,and abdominal aortic)[J].Circulation,2006,113(11):463-654.
5Bosch JL,Hunink MG.Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease[J].Radiology,1997,204(1):87-96.
6Mingoli A,Sapienza P,Feldhaus RJ,et al.Comparison of femorofemoral and aortofemoral bypass for aortoiliac occlusive disease[J].J Cardiovasc Surg (Torino),2001,42(3):381-387.
7Onohara T,Komori K,Kume M,et al.Multivariate analysis of long-term results after an axillobifemoral and aortobifemoral bypass in patients with aortoiliac occlusive disease[J].J Cardiovasc Surg (Torino),2000,41(6):905-910.
8Hunink MG,Wong JB,Donaldson MC,et al.Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease[J].Med Decis Making,1994,14(1):71-81.
9Hunink MG,Wong JB,Donaldson MC,et al.Revascularization for femoropopliteal disease:a decision and cost-effectiveness analysis[J].JAMA,1995,274(2):165-171.
10Shillinger M,Sabeti S,Loewe C,et al.Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery[J].N Engl J Med,2006,354(18):1879-1888.
